The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 05, 2022

Filed:

Jan. 10, 2014
Applicants:

Biomerieux, Marcy L'Etoile, FR;

Hospices Civils DE Lyon, Lyons, FR;

Inventors:

Marie-Angelique Cazalis, Vaulx en Velin, FR;

Maud Tournoud, Grenoble, FR;

Fabienne Venet, Lyons, FR;

Alain Lepape, Saint Genis Laval, FR;

Guillaume Monneret, Lyons, FR;

Assignees:

BIOMERIEUX, Marcy l'Etoile, FR;

HOSPICES CIVILS DE LYON, Lyons, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6883 (2018.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6883 (2013.01); G01N 33/6893 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); G01N 2800/26 (2013.01);
Abstract

The subject of the invention is a method for making an in vitro prognosis of severity for a patient in septic shock, including the following steps: (i) the level of expression of the expression product of at least one gene chosen from the lilrb2 and lilrb1 genes is measured in vitro on the basis of a biological sample taken from the patient, (ii) the level of expression of the expression product of the at least one gene is compared with a control level of expression, of the expression product of the same gene, with a good prognosis of severity, in which a level of expression of the expression product of the at least one gene below the control level of expression indicates a poor prognosis of severity for the patient, and also a kit for implementing the method.


Find Patent Forward Citations

Loading…